IMMUNIC, INC. — Form D/A

IMMUNIC, INC. of NEW YORK, X1, a company, filed a Form D amendment with the SEC on 2014-03-07. The offering totals $13.9M, of which $13.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (56)

Showing 25 of 56 people.

NameRoleLocation
Jean-Jacques E BienaimeDirectorSan Diego, CA
Phillip M CroxfordDirectorSan Diego, CA
Douglas E GodshallDirectorSan Diego, CA
Errol R HalperinDirectorChicago, IL
J. Michael MillisDirectorSan Diego, CA
Lowell E SearsDirectorBozeman, MT
Randolph C SteerDirectorSan Diego, CA
Terence E WintersDirectorSan Diego, CA
Robert A AshleyExecutive OfficerSan Diego, CA
Andrew V HenryExecutive OfficerSan Diego, CA
Andrea V LoewenExecutive OfficerSan Diego, CA
Kameron V MaxwellExecutive OfficerSan Diego, CA
Richard V MurawskiExecutive OfficerSan Diego, CA
Duane A NashExecutive OfficerSan Diego, CA
Aron P SternExecutive OfficerSan Diego, CA
Michael V SwansonExecutive OfficerSan Diego, CA
Terence E WintersExecutive OfficerSan Diego, CA
Muneer A SatterDirectorChicago, IL
Patrick WalshExecutive OfficerNew York, NY
Andreas MuehlerExecutive OfficerNew York, NY
Barclay PhillipsDirectorNew York, NY
Inderpal SinghExecutive OfficerNew York, NY
Daniel VittDirectorNew York, NY
Daniel VittExecutive OfficerNew York, NY
Duane NashDirectorNew York, NY

Other filings by this issuer (23)

Showing 15 of 23 filings.

FiledFormOfferingSold
2026-03-04D$200.0M$200.0M
2024-01-19D$240.0M$80.0M
2022-10-18D$60.0M$60.0M
2014-02-04D$12.0M$12.0M
2014-01-31D/A$32.0M$32.0M
2013-06-24D/A$22.5M$22.5M
2013-03-14D$14.3M$14.3M
2012-11-07D/A$86.1M$86.1M
2012-10-09D$76.1M$76.1M
2012-06-22D$2.5M
2012-02-17D$1.5M$930K
2011-06-23D$56.9M$22.6M
2011-06-22D/A$16.3M$16.3M
2011-02-07D/A$14.0M
2011-01-04D/A$13.4M

More